To investigate how CCL5 secreted from non-tumor cells affects the STAT3 signaling pathway, recombinant CCL5 was added to cancer cells, and changes in STAT3 and IL6 mRNA and protein expression were observed. The gene discussed is STAT3; the disease is cancer.